Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04191382
Title Phase 2 Window Study of SAR439859 Versus Letrozole in ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer (AMEERA-4)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole

SAR439859

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | BEL


No variant requirements are available.